Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas.

Papinutto N, Asteggiano C, Bischof A, Gundel TJ, Caverzasi E, Stern WA, Bastianello S, Hauser SL, Henry RG.

J Neuroimaging. 2019 Sep 30. doi: 10.1111/jon.12666. [Epub ahead of print]

PMID:
31571307
2.

Telomere Length Is Associated with Disability Progression in Multiple Sclerosis.

Krysko KM, Henry RG, Cree BAC, Lin J; University of California, San Francisco MS-EPIC Team, Caillier S, Santaniello A, Zhao C, Gomez R, Bevan C, Smith DL, Stern W, Kirkish G, Hauser SL, Oksenberg JR, Graves JS.

Ann Neurol. 2019 Nov;86(5):671-682. doi: 10.1002/ana.25592. Epub 2019 Oct 2.

PMID:
31486104
3.

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years.

Cantó E, Barro C, Zhao C, Caillier SJ, Michalak Z, Bove R, Tomic D, Santaniello A, Häring DA, Hollenbach J, Henry RG, Cree BAC, Kappos L, Leppert D, Hauser SL, Benkert P, Oksenberg JR, Kuhle J.

JAMA Neurol. 2019 Aug 12. doi: 10.1001/jamaneurol.2019.2137. [Epub ahead of print]

PMID:
31403661
4.

Long-Term Safety, Immunologic Response, and Imaging Outcomes following Neural Stem Cell Transplantation for Pelizaeus-Merzbacher Disease.

Gupta N, Henry RG, Kang SM, Strober J, Lim DA, Ryan T, Perry R, Farrell J, Ulman M, Rajalingam R, Gage A, Huhn SL, Barkovich AJ, Rowitch DH.

Stem Cell Reports. 2019 Aug 13;13(2):254-261. doi: 10.1016/j.stemcr.2019.07.002. Epub 2019 Aug 1.

5.

Longitudinal quantitative magnetic resonance imaging in adrenomyeloneuropathy.

Politi LS, Castellano A, Papinutto N, Mauro E, Pareyson D, Henry RG, Falini A, Salsano E.

Eur J Neurol. 2019 Oct;26(10):1341-1344. doi: 10.1111/ene.13959. Epub 2019 May 2.

PMID:
30932272
6.

Silent progression in disease activity-free relapsing multiple sclerosis.

University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL.

Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30.

7.

Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.

Greenfield AL, Dandekar R, Ramesh A, Eggers EL, Wu H, Laurent S, Harkin W, Pierson NS, Weber MS, Henry RG, Bischof A, Cree BA, Hauser SL, Wilson MR, von Büdingen HC.

JCI Insight. 2019 Mar 21;4(6). pii: 126599. doi: 10.1172/jci.insight.126599. eCollection 2019 Mar 21.

8.

Multisite reliability and repeatability of an advanced brain MRI protocol.

Schwartz DL, Tagge I, Powers K, Ahn S, Bakshi R, Calabresi PA, Todd Constable R, Grinstead J, Henry RG, Nair G, Papinutto N, Pelletier D, Shinohara R, Oh J, Reich DS, Sicotte NL, Rooney WD; NAIMS Cooperative.

J Magn Reson Imaging. 2019 Sep;50(3):878-888. doi: 10.1002/jmri.26652. Epub 2019 Jan 16.

PMID:
30652391
9.

Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.

Olney NT, Bischof A, Rosen H, Caverzasi E, Stern WA, Lomen-Hoerth C, Miller BL, Henry RG, Papinutto N.

PLoS One. 2018 Nov 29;13(11):e0208255. doi: 10.1371/journal.pone.0208255. eCollection 2018.

10.

Evaluation of Intra- and Interscanner Reliability of MRI Protocols for Spinal Cord Gray Matter and Total Cross-Sectional Area Measurements.

Papinutto N, Henry RG.

J Magn Reson Imaging. 2019 Apr;49(4):1078-1090. doi: 10.1002/jmri.26269. Epub 2018 Sep 9.

11.

Subcortical stimulation mapping of descending motor pathways for perirolandic gliomas: assessment of morbidity and functional outcome in 702 cases.

Han SJ, Morshed RA, Troncon I, Jordan KM, Henry RG, Hervey-Jumper SL, Berger MS.

J Neurosurg. 2018 Aug 1:1-8. doi: 10.3171/2018.3.JNS172494. [Epub ahead of print]

PMID:
30117770
12.

MRI gradient-echo phase contrast of the brain at ultra-short TE with off-resonance saturation.

Wei H, Cao P, Bischof A, Henry RG, Larson PEZ, Liu C.

Neuroimage. 2018 Jul 15;175:1-11. doi: 10.1016/j.neuroimage.2018.03.066. Epub 2018 Mar 29.

13.

An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions.

Dworkin JD, Linn KA, Oguz I, Fleishman GM, Bakshi R, Nair G, Calabresi PA, Henry RG, Oh J, Papinutto N, Pelletier D, Rooney W, Stern W, Sicotte NL, Reich DS, Shinohara RT; North American Imaging in Multiple Sclerosis Cooperative.

AJNR Am J Neuroradiol. 2018 Apr;39(4):626-633. doi: 10.3174/ajnr.A5556. Epub 2018 Feb 22.

14.

Clonidine as a preoperative sedative.

Henry RG, Raybould TP, Romond K, Kouzoukas DE, Challman SD.

Spec Care Dentist. 2018 Mar;38(2):80-88. doi: 10.1111/scd.12269. Epub 2018 Jan 24.

PMID:
29364538
15.

Harnessing electronic medical records to advance research on multiple sclerosis.

Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA.

Mult Scler. 2019 Mar;25(3):408-418. doi: 10.1177/1352458517747407. Epub 2018 Jan 9.

PMID:
29310490
16.

Ovarian aging is associated with gray matter volume and disability in women with MS.

Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A; University of California, San Francisco MS-EPIC Team,, Bacchetti P, Hauser SL, Oksenberg JR.

Neurology. 2018 Jan 16;90(3):e254-e260. doi: 10.1212/WNL.0000000000004843. Epub 2017 Dec 22.

17.

Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injury.

Cree BAC, Niu J, Hoi KK, Zhao C, Caganap SD, Henry RG, Dao DQ, Zollinger DR, Mei F, Shen YA, Franklin RJM, Ullian EM, Xiao L, Chan JR, Fancy SPJ.

Brain. 2018 Jan 1;141(1):85-98. doi: 10.1093/brain/awx312.

18.

Advances in Imaging Multiple Sclerosis.

Bischof A, Caverzasi E, Cordano C, Hauser SL, Henry RG.

Semin Neurol. 2017 Oct;37(5):538-545. doi: 10.1055/s-0037-1607278. Epub 2017 Dec 5. Review. No abstract available.

PMID:
29207413
19.

Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.

Eggers EL, Michel BA, Wu H, Wang SZ, Bevan CJ, Abounasr A, Pierson NS, Bischof A, Kazer M, Leitner E, Greenfield AL, Demuth S, Wilson MR, Henry RG, Cree BA, Hauser SL, von Büdingen HC.

JCI Insight. 2017 Nov 16;2(22). pii: 92724. doi: 10.1172/jci.insight.92724. eCollection 2017 Nov 16.

20.

In vivo characterization of brain ultrashort-T2 components.

Boucneau T, Cao P, Tang S, Han M, Xu D, Henry RG, Larson PEZ.

Magn Reson Med. 2018 Aug;80(2):726-735. doi: 10.1002/mrm.27037. Epub 2017 Dec 1.

21.

Improved three-dimensional multi-echo gradient echo based myelin water fraction mapping with phase related artifact correction.

Lee H, Nam Y, Lee HJ, Hsu JJ, Henry RG, Kim DH.

Neuroimage. 2018 Apr 1;169:1-10. doi: 10.1016/j.neuroimage.2017.11.058. Epub 2017 Dec 11.

PMID:
29191477
22.

The NAIMS cooperative pilot project: Design, implementation and future directions.

Oh J, Bakshi R, Calabresi PA, Crainiceanu C, Henry RG, Nair G, Papinutto N, Constable RT, Reich DS, Pelletier D, Rooney W, Schwartz D, Tagge I, Shinohara RT, Simon JH, Sicotte NL; NAIMS Cooperative Steering Committee.

Mult Scler. 2018 Nov;24(13):1770-1772. doi: 10.1177/1352458517739990. Epub 2017 Nov 6.

PMID:
29106329
23.

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.

Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR.

Lancet. 2017 Dec 2;390(10111):2481-2489. doi: 10.1016/S0140-6736(17)32346-2. Epub 2017 Oct 10.

24.

Cluster Confidence Index: A Streamline-Wise Pathway Reproducibility Metric for Diffusion-Weighted MRI Tractography.

Jordan KM, Amirbekian B, Keshavan A, Henry RG.

J Neuroimaging. 2018 Jan;28(1):64-69. doi: 10.1111/jon.12467. Epub 2017 Sep 21.

PMID:
28940825
25.

Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

Cysique LA, Soares JR, Geng G, Scarpetta M, Moffat K, Green M, Brew BJ, Henry RG, Rae C.

J Neurovirol. 2017 Aug;23(4):548-549. doi: 10.1007/s13365-017-0542-z. No abstract available.

PMID:
28755142
26.

Spinal cord microstructure integrating phase-sensitive inversion recovery and diffusional kurtosis imaging.

Panara V, Navarra R, Mattei PA, Piccirilli E, Cotroneo AR, Papinutto N, Henry RG, Uncini A, Caulo M.

Neuroradiology. 2017 Aug;59(8):819-827. doi: 10.1007/s00234-017-1864-5. Epub 2017 Jul 4.

PMID:
28676888
27.

Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.

Shinohara RT, Oh J, Nair G, Calabresi PA, Davatzikos C, Doshi J, Henry RG, Kim G, Linn KA, Papinutto N, Pelletier D, Pham DL, Reich DS, Rooney W, Roy S, Stern W, Tummala S, Yousuf F, Zhu A, Sicotte NL, Bakshi R; NAIMS Cooperative.

AJNR Am J Neuroradiol. 2017 Aug;38(8):1501-1509. doi: 10.3174/ajnr.A5254. Epub 2017 Jun 22.

28.

Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 -weighted brain MRI acquisitions.

Papinutto N, Bakshi R, Bischof A, Calabresi PA, Caverzasi E, Constable RT, Datta E, Kirkish G, Nair G, Oh J, Pelletier D, Pham DL, Reich DS, Rooney W, Roy S, Schwartz D, Shinohara RT, Sicotte NL, Stern WA, Tagge I, Tauhid S, Tummala S, Henry RG; North American Imaging in Multiple Sclerosis Cooperative(NAIMS).

Magn Reson Med. 2018 Mar;79(3):1595-1601. doi: 10.1002/mrm.26776. Epub 2017 Jun 15.

29.

Mindcontrol: A web application for brain segmentation quality control.

Keshavan A, Datta E, M McDonough I, Madan CR, Jordan K, Henry RG.

Neuroimage. 2018 Apr 15;170:365-372. doi: 10.1016/j.neuroimage.2017.03.055. Epub 2017 Mar 30. Review.

30.

White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

Cysique LA, Soares JR, Geng G, Scarpetta M, Moffat K, Green M, Brew BJ, Henry RG, Rae C.

J Neurovirol. 2017 Aug;23(4):539-547. doi: 10.1007/s13365-017-0524-1. Epub 2017 Mar 21. Erratum in: J Neurovirol. 2017 Jul 28;:.

PMID:
28324319
31.

Onset of secondary progressive MS after long-term rituximab therapy - a case report.

von Büdingen HC, Bischof A, Eggers EL, Wang S, Bevan CJ, Cree BA, Henry RG, Hauser SL.

Ann Clin Transl Neurol. 2016 Dec 20;4(1):46-52. doi: 10.1002/acn3.377. eCollection 2017 Jan.

32.

Language outcomes after resection of dominant inferior parietal lobule gliomas.

Southwell DG, Riva M, Jordan K, Caverzasi E, Li J, Perry DW, Henry RG, Berger MS.

J Neurosurg. 2017 Oct;127(4):781-789. doi: 10.3171/2016.8.JNS16443. Epub 2017 Jan 6.

PMID:
28059657
33.

Brain MRI atrophy quantification in MS: From methods to clinical application.

Rocca MA, Battaglini M, Benedict RH, De Stefano N, Geurts JJ, Henry RG, Horsfield MA, Jenkinson M, Pagani E, Filippi M.

Neurology. 2017 Jan 24;88(4):403-413. doi: 10.1212/WNL.0000000000003542. Epub 2016 Dec 16. Review.

34.

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative.

Nat Rev Neurol. 2016 Dec;12(12):714-722. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11. Review.

PMID:
27834394
35.

HLA Genetic Risk Burden in Multiple Sclerosis-Reply.

Isobe N, Oksenberg JR, Henry RG.

JAMA Neurol. 2016 Dec 1;73(12):1501-1502. doi: 10.1001/jamaneurol.2016.4326. No abstract available.

PMID:
27775754
36.

Gray matter segmentation of the spinal cord with active contours in MR images.

Datta E, Papinutto N, Schlaeger R, Zhu A, Carballido-Gamio J, Henry RG.

Neuroimage. 2017 Feb 15;147:788-799. doi: 10.1016/j.neuroimage.2016.07.062. Epub 2016 Aug 2.

PMID:
27495383
37.

Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia.

Mandelli ML, Vilaplana E, Brown JA, Hubbard HI, Binney RJ, Attygalle S, Santos-Santos MA, Miller ZA, Pakvasa M, Henry ML, Rosen HJ, Henry RG, Rabinovici GD, Miller BL, Seeley WW, Gorno-Tempini ML.

Brain. 2016 Oct;139(Pt 10):2778-2791. Epub 2016 Aug 6.

38.

Long-term evolution of multiple sclerosis disability in the treatment era.

University of California, San Francisco MS-EPIC Team:, Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, Caillier S, Ciocca C, Gomez R, Kanner R, Lincoln R, Lizee A, Qualley P, Santaniello A, Suleiman L, Bucci M, Panara V, Papinutto N, Stern WA, Zhu AH, Cutter GR, Baranzini S, Henry RG, Hauser SL.

Ann Neurol. 2016 Oct;80(4):499-510. doi: 10.1002/ana.24747. Epub 2016 Aug 13.

39.

Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.

Biberacher V, Schmidt P, Keshavan A, Boucard CC, Righart R, Sämann P, Preibisch C, Fröbel D, Aly L, Hemmer B, Zimmer C, Henry RG, Mühlau M.

Neuroimage. 2016 Nov 15;142:188-197. doi: 10.1016/j.neuroimage.2016.07.035. Epub 2016 Jul 16.

PMID:
27431758
40.

Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.

Isobe N, Keshavan A, Gourraud PA, Zhu AH, Datta E, Schlaeger R, Caillier SJ, Santaniello A, Lizée A, Himmelstein DS, Baranzini SE, Hollenbach J, Cree BA, Hauser SL, Oksenberg JR, Henry RG.

JAMA Neurol. 2016 Jul 1;73(7):795-802. doi: 10.1001/jamaneurol.2016.0980.

41.

Neurite Orientation Dispersion and Density Imaging Color Maps to Characterize Brain Diffusion in Neurologic Disorders.

Caverzasi E, Papinutto N, Castellano A, Zhu AH, Scifo P, Riva M, Bello L, Falini A, Bharatha A, Henry RG.

J Neuroimaging. 2016 Sep;26(5):494-8. doi: 10.1111/jon.12359. Epub 2016 May 23.

PMID:
27214558
42.

Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes.

Castellano A, Papinutto N, Cadioli M, Brugnara G, Iadanza A, Scigliuolo G, Pareyson D, Uziel G, Köhler W, Aubourg P, Falini A, Henry RG, Politi LS, Salsano E.

Brain. 2016 Jun;139(Pt 6):1735-46. doi: 10.1093/brain/aww068. Epub 2016 Apr 11.

PMID:
27068048
43.

Power estimation for non-standardized multisite studies.

Keshavan A, Paul F, Beyer MK, Zhu AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris A, Graetz C, Gröger A, Groppa S, Hafler DA, Harbo HF, Hemmer B, Jordan K, Kappos L, Kirkish G, Llufriu S, Magon S, Martinelli-Boneschi F, McCauley JL, Montalban X, Mühlau M, Pelletier D, Pattany PM, Pericak-Vance M, Cournu-Rebeix I, Rocca MA, Rovira A, Schlaeger R, Saiz A, Sprenger T, Stecco A, Uitdehaag BMJ, Villoslada P, Wattjes MP, Weiner H, Wuerfel J, Zimmer C, Zipp F; International Multiple Sclerosis Genetics Consortium. Electronic address: AIVINSON@PARTNERS.ORG, Hauser SL, Oksenberg JR, Henry RG.

Neuroimage. 2016 Jul 1;134:281-294. doi: 10.1016/j.neuroimage.2016.03.051. Epub 2016 Apr 1.

44.

Structural connectivity of the human anterior temporal lobe: A diffusion magnetic resonance imaging study.

Papinutto N, Galantucci S, Mandelli ML, Gesierich B, Jovicich J, Caverzasi E, Henry RG, Seeley WW, Miller BL, Shapiro KA, Gorno-Tempini ML.

Hum Brain Mapp. 2016 Jun;37(6):2210-22. doi: 10.1002/hbm.23167. Epub 2016 Mar 4.

45.

Ultrashort echo time and zero echo time MRI at 7T.

Larson PE, Han M, Krug R, Jakary A, Nelson SJ, Vigneron DB, Henry RG, McKinnon G, Kelley DA.

MAGMA. 2016 Jun;29(3):359-70. doi: 10.1007/s10334-015-0509-0. Epub 2015 Dec 24.

46.

Identifying preoperative language tracts and predicting postoperative functional recovery using HARDI q-ball fiber tractography in patients with gliomas.

Caverzasi E, Hervey-Jumper SL, Jordan KM, Lobach IV, Li J, Panara V, Racine CA, Sankaranarayanan V, Amirbekian B, Papinutto N, Berger MS, Henry RG.

J Neurosurg. 2016 Jul;125(1):33-45. doi: 10.3171/2015.6.JNS142203. Epub 2015 Dec 11.

PMID:
26654181
47.

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.

Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG.

JAMA Neurol. 2015 Aug;72(8):897-904. doi: 10.1001/jamaneurol.2015.0993.

48.

Age, gender and normalization covariates for spinal cord gray matter and total cross-sectional areas at cervical and thoracic levels: A 2D phase sensitive inversion recovery imaging study.

Papinutto N, Schlaeger R, Panara V, Zhu AH, Caverzasi E, Stern WA, Hauser SL, Henry RG.

PLoS One. 2015 Mar 17;10(3):e0118576. doi: 10.1371/journal.pone.0118576. eCollection 2015.

49.

2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.

Papinutto N, Schlaeger R, Panara V, Caverzasi E, Ahn S, Johnson KJ, Zhu AH, Stern WA, Laub G, Hauser SL, Henry RG.

J Magn Reson Imaging. 2015 Sep;42(3):698-708. doi: 10.1002/jmri.24819. Epub 2014 Dec 8.

50.

White matter involvement in sporadic Creutzfeldt-Jakob disease.

Caverzasi E, Mandelli ML, DeArmond SJ, Hess CP, Vitali P, Papinutto N, Oehler A, Miller BL, Lobach IV, Bastianello S, Geschwind MD, Henry RG.

Brain. 2014 Dec;137(Pt 12):3339-54. doi: 10.1093/brain/awu298. Epub 2014 Nov 2.

Supplemental Content

Loading ...
Support Center